There are no adequate data from the use of Keppra in pregnant women. Studies in animals have shown reproductive toxicity. The potential risk for humans is unknown. Keppra should not be used during pregnancy unless clearly necessary. Discontinuation of antiepileptic treatments may result in exacerbation of the disease, which could be harmful to the mother and the foetus.
Animal data show that levetiracetam is excreted in human breast milk. No data are available on the presence of levetiracetam in human breast milk. Therefore, breastfeeding is not recommended.